Due to this property, agonists of STING such as c-di-GMP and c-di-AMP have been successfully used as cancer vaccine adjuvants and 2′3′-cGAMP was found to improve responses to radiation-based cancer therapy [74,75,76]. Here, STING1 is linked to cancer.